awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33436890-E01B7112-4115-454B-899E-034E9FC84190
Q33436890-E01B7112-4115-454B-899E-034E9FC84190
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33436890-E01B7112-4115-454B-899E-034E9FC84190
A phase IIb trial of vorinostat in combination with lenalidomide and dexamethasone in patients with multiple myeloma refractory to previous lenalidomide-containing regimens.
P2860
Q33436890-E01B7112-4115-454B-899E-034E9FC84190
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33436890-E01B7112-4115-454B-899E-034E9FC84190
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9b356c81f7164ed8af0e382b489dfd7078db5d0e
P2860
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase (TDAC) inhibitor LBH589 are synergistic in myeloma cells